Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index; 9 of the 11 sources its claims cite were checked for support.

Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X

Open access

Abstract

CAH-X is a hypermobility-type Ehlers–Danlos syndrome connective tissue dysplasia affecting approximately 15% of patients with 21-hydroxylase deficiency (21-OHD) congenital adrenal hyperplasia (CAH) due to contiguous deletion of CYP21A2 and TNXB genes. The two most common genetic causes of CAH-X are CYP21A1P-TNXA/TNXB chimeras with pseudogene TNXA substitution for TNXB exons 35–44 (CAH-X CH-1) and TNXB exons 40–44 (CAH-X CH-2). A total of 45 subjects (40 families) from a cohort of 278 subjects (135 families of 21-OHD and 11 families of other conditions) were found to have excessive TNXB exon 40 copy number as measured by digital PCR. Here, we report that 42 subjects (37 families) had at least one copy of a TNXA variant allele carrying a TNXB exon 40 sequence, whose overall allele frequency was 10.3% (48/467). Most of the TNXA variant alleles were in cis with either a normal (22/48) or an In2G (12/48) CYP21A2 allele. There is potential interference with CAH-X molecular genetic testing based on copy number assessment, such as with digital PCR and multiplex ligation-dependent probe amplification, since this TNXA variant allele might mask a real copy number loss in TNXB exon 40. This interference most likely happens amongst genotypes of CAH-X CH-2 with an in trans normal or In2G CYP21A2 allele.

Overview

CoChat Summary

## TL;DR

This study shows that a common TNXA pseudogene variant carrying TNXB exon 40-like sequence can inflate TNXB exon 40 copy-number signals and potentially mask true CAH-X CH-2 deletions in molecular testing. In a cohort of 278 subjects, the variant was found in 42 subjects from 37 families, with an overall allele frequency of 10.3% (48/467).

## Key findings

  • Among 278 screened subjects, 45 from 37 unrelated families had excessive TNXB exon 40 copy number by ddPCR (2.50–5.47; cutoff 2.50), but all were confirmed as true CAH-X negative by Sanger-based testing.
  • 42 of those 45 subjects (93.3%) carried at least one TNXA variant allele homologous to TNXB exon 40, defined by SNPs rs4959086(C>G) and rs77471377(C>G); the cohort-wide allele frequency was 10.3% (48/467).
  • The TNXA variant was most often in cis with a normal CYP21A2 allele (22/48, 45.8%) or an In2G CYP21A2 allele (12/48, 25.0%); among chromosomes with known genotype, it was found on at least 13.3% (20/150) of normal CYP21A2 chromosomes and 11.8% (11/93) of In2G chromosomes.
  • The authors report a masking example: a CAH carrier with CAH-X CH-1/normal genotype had TNXB exons 35 and 40 measured as one and two copies, respectively, because of a TNXB-like TNXA allele on the normal chromosome; they argue this could create false-negative CAH-X CH-2 calls.

## Methods

  • The study used 278 subjects enrolled in an NIH Natural History Study (145 affected 21-OHD CAH patients, 116 carriers, 3 normal relatives, and 14 subjects/relatives with other diseases from 11 families).
  • Copy numbers of TNXB exons 35 and 40, C4A, and C4B had been determined previously; TNXA copy number was inferred, and TNXA variants homologous to TNXB exon 40 were assessed by allele-specific PCR followed by Sanger sequencing.
  • The main analysis compared ddPCR TNXB exon 40 copy-number results with sequencing and family genotype information to determine how often the TNXA variant co-occurred with CYP21A2 genotypes and whether it could interfere with CAH-X testing.

## Limitations

  • The paper states that Sanger plus allele-specific PCR is accurate but low-throughput and constrained by difficult 8.5 kb long-range PCR across the RCCX locus.
  • The authors note that they did not observe any true false-negative CAH-X calls in their cohort, so the masking risk is inferred from genotype patterns and one example rather than confirmed false-negative cases.
  • Evident from the text: some TNXA variant alleles could not be phased to a CYP21A2 genotype because family genotype information was unavailable (7 TNXA variant alleles), limiting complete interpretation of cis associations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/genes14020265

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Schematic diagram of CAH and CAH-X chimeric genes [10]. (A), typical bimodular RCCX module: each pair of the homologous genes is shown in similar colors, with lighter colors representing pseudogenes; two RCCX units vulnerable for gene conversion are in brackets. (B), unequal crossover between CYP21A1P and CYP21A2, or TNXA and TNXB, results in a commonly termed “30-kb deletion” CAH genotype. (C), schemes of three major subtypes of “30-kb deletion”: top, CYP21A1P/CYP21A2 chimeric genes with intact TNXB, pathogenic for CAH; middle, CYP21A1P-TNXA/TNXB chimera CAH-X CH-1 with TNXB exons 35–44 replaced by TNXA causes CAH-X due to tenascin-X haploinsufficiency; bottom, CYP21A1P-TNXA/TNXB chimera CAH-X CH-2 with TNXB exons 40–44 replaced by TNXA causes CAH-X due to a dominant negative effect. CAH-X CH-1 has an exon 35 c.11435_11524+30 deletion (light green triangle) and an exon 40 c.12174C>G mutation (small black arrow) in tandem, whereas CAH-X CH-2 has an intact exon 35 (green triangle) and an exon 40 c.12174C>G mutation. The junction site window for each chimeric gene is shown in chameleonic colors. Schemes from CYP21A1P to TNXB intron 31, which is the boundary of RCCX module homologous repeats, are shown in scale. The size of TNXB is 68 kb.
Figure 1 Schematic diagram of CAH and CAH-X chimeric genes [10]. (A), typical bimodular RCCX module: each pair of the homologous genes is shown in similar colors, with lighter colors representing pseudogenes; two RCCX units vulnerable for gene conversion are in brackets. (B), unequal crossover between CYP21A1P and CYP21A2, or TNXA and TNXB, results in a commonly termed “30-kb deletion” CAH genotype. (C), schemes of three major subtypes of “30-kb deletion”: top, CYP21A1P/CYP21A2 chimeric genes with intact TNXB, pathogenic for CAH; middle, CYP21A1P-TNXA/TNXB chimera CAH-X CH-1 with TNXB exons 35–44 replaced by TNXA causes CAH-X due to tenascin-X haploinsufficiency; bottom, CYP21A1P-TNXA/TNXB chimera CAH-X CH-2 with TNXB exons 40–44 replaced by TNXA causes CAH-X due to a dominant negative effect. CAH-X CH-1 has an exon 35 c.11435_11524+30 deletion (light green triangle) and an exon 40 c.12174C>G mutation (small black arrow) in tandem, whereas CAH-X CH-2 has an intact exon 35 (green triangle) and an exon 40 c.12174C>G mutation. The junction site window for each chimeric gene is shown in chameleonic colors. Schemes from CYP21A1P to TNXB intron 31, which is the boundary of RCCX module homologous repeats, are shown in scale. The size of TNXB is 68 kb.CC BY · PubMed Central
Figure 2 Identification of CAH-X chimeric type by droplet digital PCR (ddPCR) [10]. The copy numbers of TNXB exons 35 and 40 determined by ddPCR were used for the call of CAH-X chimeric genes.
Figure 2 Identification of CAH-X chimeric type by droplet digital PCR (ddPCR) [10]. The copy numbers of TNXB exons 35 and 40 determined by ddPCR were used for the call of CAH-X chimeric genes.CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 0 Not valid · 0 Not checked · 21 Own results and interpretations

12 more claims

Create a free account to see all 25 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 3
  • It may state two separate claims as one. 6

Create a free account to see these claims.

Citations

Cites

Show all 47 references

Cited by

See all 1

Metadata

Authors
Lao, Q., Zhou, K., Parker, M., Faucz, F. R., & Merke, D. P.
Affiliations
National Institutes of Health (US)
Corresponding author
Lao, Qizong
Venue
Genes
Publisher
MDPI AG
Published
2023-01-19
Volume
14
Issue
2
Pages
265
ISSN
2073-4425 (ISSN-L)
OpenAlex
W4317434809
Cited by
1
References
47
Citations by year
2026: 1
FWCI
0.18
Type
journal article
Language
en
Open access
Locations
  • Genes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Intramural Research Program at the National Institutes of Health (NIH)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2, copy number loss, digital PCR, multiplex ligation-dependent probe amplification, connective tissue dysplasia, allele frequency
MeSH terms
Adrenal Hyperplasia, Congenital, Genetic Testing, Humans, Pseudogenes, Steroid 21-Hydroxylase, Tenascin, Multiplex Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X. https://app.cochat.ai/papers/10.3390/genes14020265
The paper
Lao, Q., Zhou, K., Parker, M., Faucz, F. R., & Merke, D. P. (2023). Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X. Genes. https://doi.org/10.3390/genes14020265

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.